Eric HACHULLA
2,031 works · 61,362 citations · h-index 123
Top works
- Pulmonary Arterial Hypertension in France
- Antiphospholipid syndrome: Clinical and immunologic manifestations and patterns of disease expression in a cohort of 1,000 patients
- Survival in Patients With Idiopathic, Familial, and Anorexigen-Associated Pulmonary Arterial Hypertension in the Modern Management Era
- Use of Canakinumab in the Cryopyrin-Associated Periodic Syndrome
- Causes and risk factors for death in systemic sclerosis: a study from the EULAR Scleroderma Trials and Research (EUSTAR) database
- Early detection of pulmonary arterial hypertension in systemic sclerosis: A French nationwide prospective multicenter study
- A prospective, multicenter, randomized trial comparing steroids and pulse cyclophosphamide versus steroids and oral cyclophosphamide in the treatment of generalized wegener's granulomatosis
- Digital ulcers in systemic sclerosis: Prevention by treatment with bosentan, an oral endothelin receptor antagonist
- Update of EULAR recommendations for the treatment of systemic sclerosis
- Factors associated with COVID-19-related death in people with rheumatic diseases: results from the COVID-19 Global Rheumatology Alliance physician-reported registry
- Morbidity and mortality in the antiphospholipid syndrome during a 10-year period: a multicentre prospective study of 1000 patients
- Neurologic Manifestations in Primary Sjögren Syndrome
- Interstitial lung disease in polymyositis and dermatomyositis
- Cannabis Arteritis Revisited
- EULAR Sjögren's Syndrome Patient Reported Index (ESSPRI): development of a consensus patient index for primary Sjögren's syndrome
- Mapping and predicting mortality from systemic sclerosis
- Polymyositis and dermatomyositis: short term and longterm outcome, and predictive factors of prognosis.
- Safety and efficacy of rituximab in systemic lupus erythematosus: Results from 136 patients from the French autoimmunity and rituximab registry
- Infections in 252 Patients with Common Variable Immunodeficiency
- Inefficacy of infliximab in primary Sjögren's syndrome: Results of the randomized, controlled trial of remicade in primary Sjögren's syndrome (TRIPSS)